AGENT-O is a modular ontology framework that defines a semantic Agent Card for representing health-oriented AI agent systems and supports assessment of reporting completeness in scientific publications. AGENT-O was developed as an OWL 2/RDF ontology covering runtime, models, workflow, tools, clinical use, evaluation, provenance, governance, and reporting assessment. Evaluation included ontology inventory, OWL-RL reasoning, three SHACL suites, 12 SPARQL competency queries, three cases, and model-assisted reporting-completeness assessment of 279 papers across five dimensions. The ontology contained 1,962 RDF triples and 1,922 Protege axioms, with 252 active classes, 198 active object properties, and 51 datatype properties. All SHACL suites conformed on example graphs, all competency queries returned prespecified evidence, and all 279 papers were scored. Incomplete reporting was highest for runtime/architecture (84.6%), governance/safety (82.8%), and provenance/reproducibility (78.1%), compared with evaluation (25.8%) and benchmark-process alignment (29.8%). AGENT-O supported semantic Agent Card representation and reporting assessment while revealing an evaluation-specification gap: evaluation and benchmark procedures were reported more consistently than runtime architecture, governance, and reproducibility. AGENT-O provides a reusable ontology, semantic Agent Card profile, and reporting-completeness workflow for structured reporting and gap identification, but does not assess agent quality or deployment readiness.
Qingchu Jin, Felistas Mazhude, Jamie B. Rabb +3cs.LG cs.AI
Achieving early and timely diagnosis and treatment for disease is a major challenge. Recent applications of machine learning (ML) algorithms trained on patient data have shown promise in many different settings for predicting the patient health state. A challenge often faced when applying these ML algorithms is that at any given time, not all clinical variables (features) needed as input to perform prediction tasks are available. We define the concept of full-feature-capacity (FFC) to refer to prediction performance when such algorithms make use of all features on which they were trained. We then introduce Feature Sufficiency Analysis (FSA) - an analysis for determining whether a subset of all clinical features needed by an AI model is sufficient to achieve FFC. FSA estimates the underlying distributions of missing variables conditioned on features that are available. FSA provides a patient-specific assessment of whether the existing set of measured features achieves FFC. If yes, then there is no need to acquire further inputs and a ML-based prediction. We provide two case studies: prediction of need for postoperative prolonged ventilation in patients recovering from heart surgery; 10-year mortality prediction in an outpatient cohort. We also demonstrate that FSA also provides a clinically interpretable feature-ranking methodology based on prediction sufficiency, identifies intrinsically hard-to-predict patient populations, and has the potential to perform cost-aware optimization for clinical data acquisition. FSA provides a generic computational approach for determining whether incomplete clinical information is sufficient to support trustworthy AI-assisted clinical decision-making, thereby facilitating the prospective deployment of healthcare AI systems across diverse clinical settings.